AO
American Oriental Bioengineering, Inc.
AOBI · OTC
$0.01 +0.00% (+$0.00)
Market Cap ₩128.7K
P/E Ratio 0.00x
Div. Yield -
ROE -
Piotroski F-Score Weak
3/9Valuation
100 /100
Cheap PEG 0.11x
P/E 0.00x
P/B 0.00x
Growth
44 /100
Stable FCF growth 11.46%
EPS growth 56.95%
Book val. growth 38.63%
Profitability
73 /100
Strong Op. margin 10.53%
Gross margin 44.29%
Net margin 34.68%
Quality
32 /100
Poor Asset turnover 0.31x
ROIC 2.77%
ROA 10.89%
Debt
86 /100
Low Int. coverage 42.79x
Debt/Equity 0.11x
Net debt/EBITDA 0.35x
Stability
31 /100
Unstable EPS volatility 191.40%
Beta 0.21x
Profitable years 0
Bulios Scoring popisuje kvalitu a minulost firmy, ne budoucí výnos. Vysoké skóre není nákupní signál. Zjistit více
Zeptejte se StockBota na AOBI
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Shujun Liu
Employees
3,719
Headquarters
Beijing